Moderna's stock experienced a decline following a "sell" rating issued by Citi analysts. The downgrade comes after a significant 500% rally in the company's shares this year.

Moderna Shares Decline After Citi Issues Sell Rating
ModernaPharmaceuticalsAnalyst RatingsStock DeclineBiotech



